ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,498.64
0.14%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Skinbiotherapeutics Plc (SBTX)

  7. Skinbiotherapeutics Plc (SBTX) Noticias

SBTX

Skinbiotherapeutics (SBTX)

Skinbiotherapeutics Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:SBTX
FechaHoraFuenteTítuloSímboloCompañía
11/04/202405:44RNS Regulatory NewsSkinBioTherapeutics PLC Holding(s) in CompanyLSE:SBTXSkinbiotherapeutics Plc
05/04/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Conversion Notice & Total Voting RightsLSE:SBTXSkinbiotherapeutics Plc
22/03/202406:34Alliance NewsAlliance NewsSkinBioTherapeutics half-year revenue jumps on UK-based salesLSE:SBTXSkinbiotherapeutics Plc
22/03/202402:00RNS Regulatory NewsSkinBioTherapeutics PLC Half-year ReportLSE:SBTXSkinbiotherapeutics Plc
18/03/202409:17Alliance NewsAlliance NewsSkinBioTherapeutics announces research into wound healing bacteriumLSE:SBTXSkinbiotherapeutics Plc
18/03/202402:00RNS Regulatory NewsSkinBioTherapeutics PLC New research project and CSO to return to academiaLSE:SBTXSkinbiotherapeutics Plc
12/03/202402:00RNS Regulatory NewsSkinBioTherapeutics PLC Conversion Notice and Total Voting RightsLSE:SBTXSkinbiotherapeutics Plc
08/03/202403:43RNS Regulatory NewsSkinBioTherapeutics PLC Notice of ResultsLSE:SBTXSkinbiotherapeutics Plc
28/02/202414:31Alliance NewsAlliance NewsTRADING UPDATES: Avacta plans fundraise to fund clinical developmentLSE:SBTXSkinbiotherapeutics Plc
28/02/202406:41RNS Regulatory NewsSkinBioTherapeutics PLC Conversion notice and alternative financingLSE:SBTXSkinbiotherapeutics Plc
27/02/202411:42Alliance NewsAlliance NewsTRADING UPDATES: Windward extends LSEG pact; Vinanz eyes DTC tradingLSE:SBTXSkinbiotherapeutics Plc
27/02/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Positive Interim AxisBiotix Acne study resultsLSE:SBTXSkinbiotherapeutics Plc
20/02/202407:52Alliance NewsAlliance NewsSkinBio's Dermatonics launches Once Heel Balm in Asia, ME and AfricaLSE:SBTXSkinbiotherapeutics Plc
20/02/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Dermatonics to launch Once Heel Balm in AMEALSE:SBTXSkinbiotherapeutics Plc
06/02/202408:29Alliance NewsAlliance NewsIN BRIEF: SkinBioTherapeutics up after successful year for DermatonicsLSE:SBTXSkinbiotherapeutics Plc
06/02/202401:31RNS Regulatory NewsSkinBioTherapeutics PLC Dermatonics Full Year trading updateLSE:SBTXSkinbiotherapeutics Plc
26/01/202404:36Alliance NewsAlliance NewsIN BRIEF: SkinBioTherapeutics completes Dermatonics purchaseLSE:SBTXSkinbiotherapeutics Plc
26/01/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Completion of Acquisition of DermatonicsLSE:SBTXSkinbiotherapeutics Plc
25/01/202408:57Alliance NewsAlliance NewsIN BRIEF: SkinBioTherapeutics buys Dermatonics; in talks for 2nd dealLSE:SBTXSkinbiotherapeutics Plc
25/01/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC Acquisition of DermatonicsLSE:SBTXSkinbiotherapeutics Plc
25/01/202401:00RNS Regulatory NewsSkinBioTherapeutics PLC £5.0m Convertible Bond Facility & First DrawdownLSE:SBTXSkinbiotherapeutics Plc
29/12/202307:29Alliance NewsAlliance NewsSkinBioTherapeutics suffers acquisition delay but aims for early 2024LSE:SBTXSkinbiotherapeutics Plc
29/12/202304:49UK RegulatorySkinBioTherapeutics PLC Result of AGMLSE:SBTXSkinbiotherapeutics Plc
29/12/202302:13UK RegulatorySkinBioTherapeutics PLC Update on transaction timelines to early 2024LSE:SBTXSkinbiotherapeutics Plc
06/12/202301:00UK RegulatorySkinBioTherapeutics PLC Notice of AGM and posting of Annual ReportLSE:SBTXSkinbiotherapeutics Plc
30/11/202315:10Alliance NewsAlliance NewsEARNINGS AND TRADING: Dispensa and SkinBioTherapeutics losses widenLSE:SBTXSkinbiotherapeutics Plc
30/11/202311:25UK RegulatorySkinBioTherapeutics PLC Final ResultsLSE:SBTXSkinbiotherapeutics Plc
30/11/202308:25Alliance NewsAlliance NewsTRADING UPDATES: SkinBio launches food supplement on AmazonLSE:SBTXSkinbiotherapeutics Plc
30/11/202301:00UK RegulatorySkinBioTherapeutics PLC AxisBiotix-Ps(TM) to launch on Amazon UKLSE:SBTXSkinbiotherapeutics Plc
22/11/202301:00UK RegulatorySkinBioTherapeutics PLC Update regarding Nominated Adviser and BrokerLSE:SBTXSkinbiotherapeutics Plc
 Showing the most relevant articles for your search:LSE:SBTX

Su Consulta Reciente

COIN
ETHUSD
Ethereum
NASDAQ
AAPL
Apple
USOTC
BASFY
BASF (QX)
NYSE
AXP
American Express
NYSE
MRK
Merck
NYSE
JPM
JP Morgan Chase
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
NYSE
VZ
Verizon Communications
NYSE
KO
Coca Cola
FX
EURUSD
Euro vs US Dollar
USOTC
RHHBY
Roche (QX)
FX
EURMXN
Euro vs MXN
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados